Neuroscience R&D newsroom

Thank you for visiting Neuroscience newsroom!

Below, please find our leadership, our meeting news, and more information about our progress and commitment to developing innovative medicines focused on neurodegenerative disorders, such as Alzheimer’s disease and Parkinson’s disease; neuroscience-autoantibody diseases, such as myasthenia gravis and chronic inflammatory demyelinating polyneuropathy; neuropsychiatric disorders, such as major depressive disorder and bipolar disorder.